I just scanned CRSP, and they are doing research on 1) cancer cells 2) Diabetes with new DNA modification technology which is similar to MRNA & BNTX on Covid-19 (RNA technology).
They (CRSP) has 3 products which has success (Oct 2020 they claimed) that made appx 200% increase in share price which is also getting corrected year-end now. They have tie-up with vertex pharma (similar to PFE & BNTX) for commercialization of their CTX110.
ARK investments has the highest stake holder with 11.97% ($1.4B), next comes Capital International Investors 10.47%($1.2B).
Looks like they do not sufficient order book - as of date - expecting eps 1.32 (loss) next two quarters (Refinitiv). However, company is at 10B mcap. If they succeed in making cancer and diabetes drug, they have major world potential.
You please do some research on fundamentals. Even this is getting corrected, you can review some EWT and possibly take some position when you are comfortable.
Since it is similar stock, I stay with BNTX & MRNA, but review later on CRSP.
Since you have fidelity, you just compare BNTX vs CRSP and see the difference with “Earnings” & “Insiders”.